日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reining in strangles: Absence of disease in horses vaccinated with a DIVA-compatible recombinant fusion protein vaccine, Strangvac, following natural exposure to Streptococcus equi subspecies equi

控制马链球菌病:接种与DIVA兼容的重组融合蛋白疫苗Strangvac的马匹,在自然感染马链球菌亚种后,未出现马链球菌病症状。

Gröndahl, Gittan; Righetti, Francesco; Aspán, Anna; Bjerketorp, Joakim; Frosth, Sara; Frykberg, Lars; Jacobsson, Karin; Guss, Bengt; Paillot, Romain; Flock, Jan-Ingmar; Henriques-Normark, Birgitta; Waller, Andrew S

Closing the Stable Door on Strangles: Serological Responses of Vaccinated Horses on a Farm Following the Arrival of a New Horse

关闭马鼻疽的大门:新马到来后,农场中已接种疫苗的马匹的血清学反应

Rask, Erika; Righetti, Francesco; Ruiz, Aymé; Bjerketorp, Joakim; Frosth, Sara; Frykberg, Lars; Jacobsson, Karin; Guss, Bengt; Flock, Jan-Ingmar; Henriques-Normark, Birgitta; Hartman, Emma; Gustafsson, Agneta; Paillot, Romain; Waller, Andrew S

Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer

211At标记farletuzumab对腹腔注射播散性卵巢癌小鼠模型的治疗效果评估

Stig Palm, Tom Bäck, Emma Aneheim, Andreas Hallqvist, Ragnar Hultborn, Lars Jacobsson, Holger Jensen, Sture Lindegren, Per Albertsson

Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200

亲本鼠单克隆抗体 MX35 (Anti-NaPi2b) 及其人源化版本 Rebmab200 的结合亲和力、特异性和比较生物分布

Sture Lindegren, Luciana N S Andrade, Tom Bäck, Camila Maria L Machado, Bruno Brasil Horta, Carlos Buchpiguel, Ana Maria Moro, Oswaldo Keith Okamoto, Lars Jacobsson, Elin Cederkrantz, Kohshin Washiyama, Emma Aneheim, Stig Palm, Holger Jensen, Maria Carolina B Tuma, Roger Chammas, Ragnar Hultborn, Pe